A detailed history of Chesapeake Capital Corp /Il/ transactions in Grifols Sa stock. As of the latest transaction made, Chesapeake Capital Corp /Il/ holds 16,500 shares of GRFS stock, worth $156,255. This represents 0.13% of its overall portfolio holdings.

Number of Shares
16,500
Holding current value
$156,255
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$6.28 - $9.38 $103,620 - $154,770
16,500 New
16,500 $148 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $6.43B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Chesapeake Capital Corp /Il/ Portfolio

Follow Chesapeake Capital Corp /Il/ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chesapeake Capital Corp /Il/, based on Form 13F filings with the SEC.

News

Stay updated on Chesapeake Capital Corp /Il/ with notifications on news.